Publicaciones en colaboración con investigadoras/es de Centro de Investigacion Biomedica en Red de Salud Mental (75)

2024

  1. Alcohol Triggers the Accumulation of Oxidatively Damaged Proteins in Neuronal Cells and Tissues

    Antioxidants, Vol. 13, Núm. 5

  2. Effect of antipsychotic drugs on group II metabotropic glutamate receptor expression and epigenetic control in postmortem brains of schizophrenia subjects

    Translational Psychiatry, Vol. 14, Núm. 1

  3. Effects of cannabidiol in post-stroke mood disorders in neonatal rats

    Pediatric Research

  4. High number of mitochondrial DNA alterations in postmortem brain tissue of patients with schizophrenia compared to healthy controls

    Psychiatry Research, Vol. 337

  5. NRN1 epistasis with BDNF and CACNA1C: mediation effects on symptom severity through neuroanatomical changes in schizophrenia

    Brain Structure and Function, Vol. 229, Núm. 5, pp. 1299-1315

  6. Next-Generation Proteomics of Brain Extracellular Vesicles in Schizophrenia Provide New Clues on the Altered Molecular Connectome

    Biomedicines, Vol. 12, Núm. 1

  7. Permissive epigenetic regulatory mechanisms at the histone level are enhanced in postmortem dorsolateral prefrontal cortex of individuals with schizophrenia

    Journal of Psychiatry and Neuroscience, Vol. 49, Núm. 1, pp. E35-E44

2023

  1. Agonistic properties of a series of psychotropic drugs at 5-HT1A receptors in rat and human brain membranes determined by [35S]GTPγS binding assay

    Pharmacological Reports, Vol. 75, Núm. 2, pp. 266-275

  2. Ethanol and illicit drugs acute use and abuse as risk factors for suicide: A case–control study based on forensic autopsies in the Basque Country, Spain

    Revista de Psiquiatria y Salud Mental

  3. Isolation and Differentiation of Neurons and Glial Cells from Olfactory Epithelium in Living Subjects

    Molecular Neurobiology, Vol. 60, Núm. 8, pp. 4472-4487

  4. Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer’s Disease

    Pharmaceutics, Vol. 15, Núm. 10

  5. The Matricellular Protein Hevin Is Involved in Alcohol Use Disorder

    Biomolecules, Vol. 13, Núm. 2

2022

  1. Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients

    Addiction Biology, Vol. 27, Núm. 6

  2. Glutamate, Glutamatergic Drugs and Schizophrenia

    Glutamate and Neuropsychiatric Disorders: Current and Emerging Treatments (Springer International Publishing), pp. 493-521

  3. Molecular mechanisms underlying cannabis-induced risk of psychosis

    Cannabis and the Developing Brain (Elsevier), pp. 197-242

2021

  1. 5-HT2A receptor- and M1 muscarinic acetylcholine receptor-mediated activation of Gαq/11 in postmortem dorsolateral prefrontal cortex of opiate addicts

    Pharmacological Reports, Vol. 73, Núm. 4, pp. 1155-1163

  2. 5-HT2A receptor-mediated Gαq/11 activation in psychiatric disorders: A postmortem study

    World Journal of Biological Psychiatry, Vol. 22, Núm. 7, pp. 505-515

  3. Benzofuranyl-2-imidazoles as imidazoline I2 receptor ligands for Alzheimer's disease

    European Journal of Medicinal Chemistry, Vol. 222

  4. Characterization of Hevin (SPARCL1) Immunoreactivity in Postmortem Human Brain Homogenates

    Neuroscience, Vol. 467, pp. 91-109

  5. Characterization of dopamine D2 receptor coupling to G proteins in postmortem brain of subjects with schizophrenia

    Pharmacological Reports, Vol. 73, Núm. 4, pp. 1136-1146